Modeling Alzheimer's disease immune therapy mechanisms: Interactions of human postmortem microglia with antibody-opsonized amyloid beta peptide

Journal of Neuroscience Research

Volumn 70, Issue 4, 2002, Pages 599-610

  Lue, Lih Fen ^a   Walker, Douglas G ^a  

^a SUN HEALTH RESEARCH INSTITUTE   (United States)

Author keywords

Cell culture; Cytokines; Inflammation; Neuropathology; Reactive oxygen

Indexed keywords

AMYLOID BETA PROTEIN; COLONY STIMULATING FACTOR 1; FC RECEPTOR; FC RECEPTOR I; FC RECEPTOR II; FC RECEPTOR IIA; FC RECEPTOR IIB; FC RECEPTOR III; IMMUNOGLOBULIN G; INTERLEUKIN 10; MESSENGER RNA; MONOCLONAL ANTIBODY; RECEPTOR SUBTYPE; SUPEROXIDE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIGEN ANTIBODY COMPLEX; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNIZATION; IMMUNOTHERAPY; INFLAMMATION; MICROGLIA; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RNA ANALYSIS; SENILE PLAQUE; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANTIBODIES; CELLS, CULTURED; CULTURE MEDIA, CONDITIONED; CYTOKINES; FRONTAL LOBE; HUMANS; IMMUNOTHERAPY; MICROGLIA; OPSONIN PROTEINS; PEPTIDE FRAGMENTS; PHAGOCYTOSIS; RECEPTORS, IGG; RNA, MESSENGER; SUPEROXIDES;

EID: 0037110640     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/jnr.10422     Document Type: Article

References (43)

1. Akiyama H, McGeer PL. 1990. Brain microglia constitutively express beta-2 integrins. J Neuroimmunol 30:81-93.
2. Ard MD, Cole GM, Wei J, Mehrle AP, Fratkin JD. 1996. Scavenging of Alzheimer's amyloid beta-protein by microglia in culture. J Neurosci Res 43:190-202.
3. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. 1993. Cytotoxicity of microglia. Glia 7:111-118.
4. Bard F, Cannon C, Barbour R, Burke RL, Games D, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Lieberburg I, Motter R, Nguyen M, Soriano F, Vasquez N, Weiss K, Welch B, Seubert P, Schenk D, Yednock T. 2000. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med 6:916-919.
5. Brazil MI, Chung H, Maxfield FR. 2000. Effects of incorporation of immunoglobulin G and complement component Clq on uptake and degradation of Alzheimer's disease amyloid fibrils by microglia. J Biol Chem 275:16941-16947.
6. Chung H, Brazil MI, Soe TT, Maxfield FR. 1999. Uptake, degradation, and release of fibrillar and soluble forms of Alzheimer's amyloid beta-peptide by microglial cells. J Biol Chem 274:32301-32308.
7. - forming NADPH oxidase in microglia, monocytes and neutrophils. A possible inflammatory mechanism of neuronal damage in Alzheimer's disease. J Biol Chem 274:15493-15499.
8. DeMattos RB, Bales KR, Cummins DJ, Dodart JC, Paul SM, Holtzman DM. 2001. Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc Natl Acad Sci USA 98:8850-8855.
9. DeMattos RB, Bales KR, Cummins DJ, Paul SM, Holtzman DM. 2002. Brain to plasma amyloid-beta efflux: A measure of brain amyloid burden in a mouse model of Alzheimer's disease. Science 295:2264-2267.
10. Dickson DW. 1997. The pathogenesis of senile plaques. J Neuropathol Exp Neurol 56:321-339.
11. Dodart JC, Bales KR, Gannon KS, Greene SJ, DeMattos RB, Mathis C, DeLong CA, Wu S, Wu X, Holtzman DM, Paul SM. 2002. Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat Neurosci 5:452-457.
12. Egg R, Reindl M, Deisenhammer F, Linington C, Berger T. 2001. Anti-MOG and anti-MBP antibody subclasses in multiple sclerosis. Mult Scler 7:285-289.
13. Fossati G, Bucknall RC, Edwards SW. 2001. Fcγ amma receptors in autoimmune diseases. Eur J Clin Invest 31:821-831.
14. Gerber JS and Mosser DM. 2001. Reversing lipopolysaccharide toxicity by ligating the macrophage Fc gamma receptors. J Immunol 166:6861-6868.
15. Giulian D, Haverkamp LJ, Yu JH, Karshin W, Tom D, Li J, Kirkpatrick J, Kuo YM, Roher AE. 1996. Specific domains of beta-amyloid from Alzheimer plaque elicit neuron killing in human microglia. J Neurosci 16:6021-6037.
16. Hashimoto S-I, Yamada M, Motoyoshi K, Akagawa KS. 1997. Enhancement of macrophage colony-stimulating factor-induced growth and differentiation of human monocytes by interleukin-10. Blood 89:315-321.
17. Janus C, Pearson J, McLaurin J, Mathews PM, Jiang Y, Schmidt SD, Chishti MA, Horne P, Heslin D, French J, Mount HT, Nixon RA, Mercken M, Bergeron C, Fraser PE, St George-Hyslop P, Westaway D. 2000. A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408:979-982.
18. Kalback W, Watson MD, Kokjohn TA, Kuo YM, Weiss N, Luehrs DC, Lopez J, Brune D, Sisodia SS, Staufenbiel M, Emmerling M, Roher AE. 2002. APP transgenic mice Tg2576 accumulate Abeta peptides that are distinct from the chemically modified and insoluble peptides deposited in Alzheimer's disease senile plaques. Biochemistry 41:922-928.
19. Kuo YM, Kokjohn TA, Beach TG, Sue LI, Brune D, Lopez JC, Kalback WM, Abramowski D, Sturchler-Pierrat C, Staufenbiel M, Roher AE. 2001. Comparative analysis of amyloid beta chemical structure and amyloid plaque morphology of transgenic mice and Alzheimer disease brains. J Biol Chem 276:12991-12998.
20. Le W, Rowe D, Xie W, Ortiz I, He Y, Appel SH. 2001. Microglial activation and dopaminergic cell injury: An in vitro model relevant to Parkinson's disease. J Neurosci 21:8447-8455.
21. Lue LF, Brachova L, Walker DG, Rogers J. 1996. Characterization of glial cultures from rapid autopsies of Alzheimer's and control patients. Neurobiol Aging 17:421-429.
22. Lue LF, Walker DG, Brachova L, Beach TG, Rogers J, Schmidt AM, Stern D, Yan S.D. 2001a. Involvement of microglial receptor for advanced glycation endproducts (RAGE) in Alzheimer's disease: Identification of a cellular activation mechanism. Exp Neurol 171:29-45.
23. Lue LF, Walker DG, Rogers J. 2001b. Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol Aging 22:945-956.
24. Markesbery WP, and Carney JM. 1999. Oxidative alterations in Alzheimer's disease. Brain Pathol 9:133-146.
25. McGeer PL, Schulzer M, McGeer EG. 1996. Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: A review of 17 epidemiologic studies. Neurology 47:425-432.
26. Morgan D, Diamond DM, Gottschall PE, Ugen KE, Dickey C, Hardy J, Duff K, Jantzen P, DiCarlo G, Wilcock D, Connor K, Hatcher J, Hope C, Gordon M, Arendash GW. 2000. A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408:982-985.
27. Munch G, Robinson SR. 2002. Alzheimer's vaccine: A cure as dangerous as the disease? J Neural Transm 109:537-539.
28. Neuroinflammation Working Group. 2000. Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421.
29. Peress NS, Fleit HB, Perilto E, Kuljis R, Pezzutto C. 1993. Identification of Fc gamma RI, II and III on normal human brain ramified microglia and on microglia in senile plaques in Alzheimer's disease. J Neuroimmunol 48:71-79.
30. Podczasy JJ, Wei R. 1988. Reduction of iodonitrotetrazolium violet by superoxide radicals. Biochem Biophys Res Commun 150:1294-1301.
31. Ravetch JV, Bolland S. 2001. IgG Fc receptors. Annu Rev Immunol 19:275-290.
32. Ravetch JV, Lanier LL. 2000. Immune inhibitory receptors. Science 290: 84-89.
33. Rogers J, Lue LF. 2001. Microglial chemotaxis, activation, and phagocytosis of amyloid β peptide as linked phenomena in Alzheimer's disease. Neurochem Int 39:333-340.
34. Schenk D, Barbour R, Dunn W, Gordon G, Grajeda H, Guido T, Hu K, Huang J, Johnson-Wood K, Khan K, Kholodenko D, Lee M, Liao Z, Lieberburg I, Motter R, Mutter L, Soriano F, Shopp G, Vasquez N, Vandevert C, Walker S, Wogulis M, Yednock T, Games D, Seubert P. 1999. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177.
35. Sigurdsson EM, Scholtzova H, Mehta PD, Frangione B, Wisniewski T. 2001. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice. Am J Pathol 159:439-447.
36. Sutterwala FS, Noel GJ, Salgame P, Mosser DM. 1998. Reversal of proinflammatory responses by ligating the macrophage Fcγ amma receptor type I. J Exp Med 188:217-222.
37. Tan AS, Berridge MV. 2000. Superoxide produced by activated neutrophils efficiently reduces the tetrazolium salt, WST-1 to produce a soluble formazan: A simple colorimetric assay for measuring respiratory burst activation and for screening anti-inflammatory agents. J Immunol Methods 238:59-68
38. Ulvestad E, Williams K, Matre R, Nyland H, Olivier A, Antel J. 1994. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J Neuropathol Exp Neurol 53: 27-36.
39. Van Muiswinkel FL, Veerhuis R, Eikelenboom P. 1996. Amyloid beta protein primes cultured rat microglial cells for an enhanced phorbol 12-myristate 13-acetate-induced respiratory burst activity. J Neurochem 66:2468-2476.
40. Walker DG, Kim SU, McGeer PL. 1995. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J Neurosci Res 40:478-493.
41. Walker DG, Lue LF, Beach TG. 2002. Increased expression of the urokinase plasminogen-activator receptor in amyloid beta peptide-treated human brain microglia and in AD brains. Brain Res 926:69-79.
42. Webster SD, Bradt BM, Rogers J, Cooper NR. 1997. Aggregation state-dependent activation of the classical complement pathway by the amyloid beta peptide. J Neurochem 69:388-398.
43. Webster SD, Galvan MD, Ferran E, Garzon-Rodriguez W, Glabe CG, Tenner AJ. 2001. Antibody-mediated phagocytosis of the amyloid beta-peptide in microglia is differentially modulated by C1q. J Immunol 166:7496-7503.